EICHOR
● Completed
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
Condition: Chronic Inducible Urticaria · Sponsor: Evommune, Inc.
About this study
This phase 2a trial will evaluate the safety and efficacy of EVO756 in subjects with chronic inducible urticaria, including symptomatic dermographism and cold urticaria.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (18)
| Cahaba Dermatology & Skin Health Center, LLC | Birmingham, Alabama, United States | — |
| California Allergy and Asthma Medical Group | Los Angeles, California, United States | — |
| Integrative Skin Science and Research | Sacramento, California, United States | — |
| West Dermatology Research Center | San Diego, California, United States | — |
| Advanced Clinical Research Institute | Tampa, Florida, United States | — |
| Aeroallergy Research Laboratories of Savannah, Inc. | Savannah, Georgia, United States | — |
| Treasure Valley Medical Research | Boise, Idaho, United States | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis, Indiana, United States | — |
| Southern Indiana Clinical Trials | New Albany, Indiana, United States | — |
| Indiana Clinical Trials Center, P.C. | Plainfield, Indiana, United States | — |
| DelRicht Research | Baton Rouge, Louisiana, United States | — |
| Chesapeake Clinical Research, Inc | White Marsh, Maryland, United States | — |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06603220